BSE filing, NSE: PPLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Piramal Pharma Ltd: key numbers
- Share price
- ₹232.80
- Market cap
- ₹30,994 Cr
- Revenue (annual)
- ₹8,869 Cr
- Net profit (annual)
- ₹-325.9 Cr
- P/E (TTM)
- -148.4×Sector 46.1×
- Promoter holding
- 34.80%+0.00% QoQ
- FII holding
- 13.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Piramal Pharma Ltd
All →Piramal Pharma Investor Presentation: Key Takeaways
Q2FY27 revenue ₹2,617 Cr (+28% YoY), EBITDA margin 14.7% (+372 bps), PAT ₹5 Cr vs loss of ₹99 Cr. FY27 revenue growth outlook raised to 19-20%.
Piramal Pharma Results Update
Piramal Pharma released its Q2/H1 FY27 press release reporting revenue of Rs. 2,617 crore for Q2 and Rs. 4,887 crore for H1, with EBITDA up 72%. The filing also upgrades FY27 revenue growth guidance to 19–20%.
Piramal Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹5 Cr
Piramal Pharma Ltd reported revenue from operations of ₹2,617 Cr (+28.1% YoY) and net profit of ₹5 Cr for Q2 FY27.
- Key figure
- Net profit ₹5 Cr
Piramal Pharma Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026. The report details equity distribution among promoters and public shareholders.
Piramal Pharma Board Meeting Date
Piramal Pharma Limited has scheduled a board meeting on October 27, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
Piramal Pharma Adverse Business Impact
Piramal Pharma announced that its sales and distribution arrangement with Bayer Pharmaceuticals will expire on December 31, 2026, and will not be renewed.
- From
- Bayer Pharmaceuticals Private Limited
Other share pledge announcements
All →TVS Holdings Share Pledge
Promoter trusts pledged TVS Holdings shares to JM Financial entities as security for credit facilities. The pledge covers 16,75,800 shares, or 8.28% of total share capital.
Paisalo Digital Share Pledge
Equilibrated Venture Cflow, a promoter group entity, pledged 2.98 crore Paisalo shares on October 26, 2026. The pledge secures a Rs.25 Crore third-party loan from Jio Credit.
- Value
- ₹25.00 Cr
Paisalo Digital Share Pledge
Promoter group entity Equilibrated Venture Cflow pledged 1,03,63,523 shares, valued at Rs.79.59 Crore, on October 26, 2026. Promoter holding stays at 20.64% after the pledge.
- Value
- ₹79.59 Cr
Billionbrains Garage Ventures Share Pledge
Golden Oak Trust (promoter group) pledged 1,50,000 shares of Billionbrains Garage Ventures to Aditya Birla Capital Ltd. The pledge covers 0.24% of total share capital, dated 19-Oct-2026.
Medplus Health Services Share Pledge
Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).
Royal Sense Share Pledge
Royal Sense promoter Rishabh Arora released a pledge on 10,00,000 shares on September 17, 2026. A supporting letter corrects the post-event encumbered holding to nil.